From Standard of Care
←Older revision | Newer revision→
Past-year and lifetime prevalence 1.14% and 1.6% respectively in adults.
Pathological gambling-at-risk populations-adolescents, adults with substance abuse and individuals in a gambling venue have much higher prevalence rates.
High-risk groups include males, blacks, individuals with a family history and individuals of lower socioeconomic status.
Problem gambling is seen as a less busy or form of a gambling disorder.
Has been linked to the dopamine agonist treatment, including pramipexole, ropinirole, cabergoline, or bromocriptine.
Rarely is this associated with carbidopadopa/levodopa monotherapy.
Prevalence varies worldwide with rates of pathological gambling in the US ranging from 0.42 1.1% of adults, 1 to 2% identified as problem gamblers (Toce-Gerstein M et al).